The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Research

Research Focus

The World Health Organization (WHO), states that cancer is among the leading causes of morbidity and mortality worldwide, with approximately 14 million new cases and 8.2 million cancers related deaths in 2012. Furthermore, the number of new cases is expected to rise by about 70% over the next 2 decades. In Sweden, someone is diagnosed with cancer every tenth minutes, which is the equivalent of 50.000 persons per year.

Cancer is not one disease, but hundreds, that develops when multiple mutations in a cell result in escape of the cellular proofreading system. In addition, these cells further acquire properties that make them immortal and difficult to eradicate by state of the art therapy, in many cases resulting in poor prognosis for the patient. 

MAD for Cancer is a translational cancer program based on a multifocal strategy to fight cancer. By combining eight different areas of expertise (Proteomics, Genomics, Targeted Therapy, Molecular Diagnostics, Chemical Biology, Stromal Biology, psychological Resilience and Cancer Stem Cells), we will come one step closer to conquering cancer.